{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:38:37Z","timestamp":1784299117408,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jaccas.2025.103755","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T18:49:08Z","timestamp":1750272548000},"page":"103755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Ranolazine in Persistent Atrial Fibrillation"],"prefix":"10.1016","volume":"30","author":[{"given":"Sagarika","family":"Raman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Rutherford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calum","family":"Presslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honey","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alykhan","family":"Bandali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moloy","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jaccas.2025.103755_bib1","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","volume":"9","author":"Valembois","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.jaccas.2025.103755_bib2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000139333.83620.5D","article-title":"Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties","volume":"110","author":"Antzelevitch","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jaccas.2025.103755_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/europace\/euu217","article-title":"Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial","volume":"17","author":"Scirica","year":"2015","journal-title":"Europace"},{"issue":"3","key":"10.1016\/j.jaccas.2025.103755_bib4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1540-8159.2011.03298.x","article-title":"The use of ranolazine to facilitate electrical cardioversion in cardioversion-resistant patients: a case series","volume":"35","author":"Murdock","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.jaccas.2025.103755_bib5","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.hrthm.2015.01.021","article-title":"Ranolazine in the treatment of atrial fibrillation: results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study","volume":"12","author":"De Ferrari","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jaccas.2025.103755_bib6","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijcard.2016.11.103","article-title":"Ranolazine for rhythm control in atrial fibrillation: a systematic review and meta-analysis","volume":"227","author":"Guerra","year":"2017","journal-title":"Int J Cardiol"},{"issue":"15","key":"10.1016\/j.jaccas.2025.103755_bib7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.jacc.2010.08.600","article-title":"Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation","volume":"56","author":"Burashnikov","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.jaccas.2025.103755_bib8","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1111\/1755-5922.12035","article-title":"Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation","volume":"31","author":"Frommeyer","year":"2013","journal-title":"Cardiovasc Ther"},{"issue":"5","key":"10.1016\/j.jaccas.2025.103755_bib9","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1161\/CIRCEP.115.002856","article-title":"The HARMONY trial: combined ranolazine and dronedarone in the management of paroxysmal atrial fibrillation: mechanistic and therapeutic synergism","volume":"8","author":"Reiffel","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"Suppl. 1","key":"10.1016\/j.jaccas.2025.103755_bib10","first-page":"i517","article-title":"The role of ranolazine alone or in combination with a class III anti-arrhythmic drug for DC cardioversion for persistent AF","volume":"26","author":"Raman","year":"2024","journal-title":"Europace"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925005339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084925005339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T18:49:10Z","timestamp":1750272550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084925005339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":10,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2666084925005339"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.103755","relation":{},"ISSN":["2666-0849"],"issn-type":[{"value":"2666-0849","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ranolazine in Persistent Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2025.103755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103755"}}